Pharmagreen Biotech Inc.

PHBI

Explore Our Financial Data > Companies > Pharmagreen Biotech Inc.
{{popupValue}}
{{popupSubtitle}}
Documentation
Excel
API
Download

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
PHBI
CIK0001435181
SIC4581
SectorTransportation, Communications, Electric, Gas, And Sanitary Services
Industry CategoryTransportation
Industry GroupAir Transportation

Contact

Address2987 BLACKBEAR COURT, COQUITLAM, A1, V3E3A2
Website pharmagreen.ca
Phone702-803-9404
CEON/A
EmployeesN/A

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$1,560.00
Pre-Tax Income$-683,910.00
Net Income$-500,710.00
Net Income to Common$-660,401.00
EPSN/A
View All
Balance Sheet
Cash$5,315.00
Assets$140,313.00
Liabilities$2.29 million
Common Equity$-2.10 million
Liabilities & Equity$140,313.00
View All
Cash Flow Statement
Net Income$-500,710.00
Cash From Operating Activities$-138,511.00
Cash From Investing ActivitiesN/A
Cash From Financing Activities$83,962.00
Change in Cash$14,019.00
View All
Calculations
NOPAT$-421,513.40
EBITDA$-661,389.00
Price to EarningsN/A
Price to BookN/A
ROE24.49%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project

CARSON CITY, Nev., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is thrilled to highlight the significant revenue potential from its latest project under development. During a special session on Creative Spaces, hosted on X on Monday, October 7, 2024, CEO Peter Wojcik shared exciting insights into the company's business advancements and growth strategies. Pharmagreen is developing a specialized form of cannabis oil known as Live Ro

Article Link

Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress

CARSON CITY, NV, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is pleased to announce the continued advancement of its business development efforts on a significant project in collaboration with a foreign government. Considerable progress has been made, and the Company is optimistic about the wide-ranging benefits this initiative will bring to all involved parties. By incorporating Pharmagreen’s proprietary Standard Organic Non-Sp

Article Link

PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its’ Nutraceutical Formulations

CARSON CITY, NV / ACCESSWIRE / January 24, 2024 / Pharmagreen Biotech, Inc., (OTC PINK:PHBI), "Pharmagreen" or the "Company" is pleased to announce the signing of a supply agreement with SierraSil® Health Inc., a manufacturer specializing in a proprietary ...

Article Link

PHBI – Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation

CARSON CITY, NV, Sept. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), “Pharmagreen” or the “Company” is pleased to announce that it has been approved by Amazon Seller Central for online sales via Amazon’s e-commerce platform for its MaxGenomicTM Supplement. https://www.amazon.com/dp/B0C9C656KR?ref=myi_title_dp The company is also developing additional sales channels, both online and brick-and-mortar, for the MaxGenomicTM supplements. Pharmagreen’s l

Article Link

PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product

CARSON CITY, NV, Feb. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), “Pharmagreen” or the “Company” is pleased to announce that it has completed development of its first formulated nutraceutical product and has commenced online sales via the Shopify ecommerce platform of its MaxGenomic™ Supplement. The company is also pleased to have entered the nutraceutical industry with this product development and be part of this multi-hundred-billion-dollar ind

Article Link